Renal cancer metastatic: Which Medications Are Safest? (90 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
90 medications are used for Renal cancer metastatic, with 2,920 combined adverse event reports. The most reported drugs for Renal cancer metastatic are SUNITINIB MALATE and AXITINIB.
2,920
Total Reports
90
Drugs Used
All Medications for Renal cancer metastatic Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| SUNITINIB MALATE | Sunitinib malate | 871 | 6,028 | 5,720 | 27.9% |
| AXITINIB | INLYTA | 456 | 3,141 | 4,050 | 19.8% |
| NIVOLUMAB | OPDIVO | 428 | 23,086 | 36,530 | 26.3% |
| CABOZANTINIB S-MALATE | CABOMETYX | 411 | 4,203 | 6,193 | 10.7% |
| PAZOPANIB | Pazopanib | 366 | 5,612 | 4,347 | 26.5% |
| PEMBROLIZUMAB | KEYTRUDA | 188 | 15,543 | 35,472 | 18.6% |
| IPILIMUMAB | YERVOY | 142 | 8,043 | 17,031 | 22.0% |
| EVEROLIMUS | EVEROLIMUS | 90 | 8,374 | 11,211 | 21.1% |
| LENVATINIB | Lenvima | 75 | 4,449 | 19,975 | 13.2% |
| SUTENT | - | 45 | 386 | 259 | 32.2% |
| ZOLEDRONIC ACID | Zoledronic acid | 30 | 5,240 | 8,346 | 15.6% |
| TEMSIROLIMUS | Temsirolimus | 29 | 361 | 727 | 21.9% |
| SUNITINIB | - | 27 | 306 | 430 | 17.2% |
| AVELUMAB | BAVENCIO | 26 | 861 | 1,630 | 23.7% |
| INLYTA | - | 22 | 113 | 75 | 22.3% |
| SORAFENIB | sorafenib | 22 | 2,489 | 3,547 | 22.8% |
| VOTRIENT | - | 22 | 244 | 207 | 40.3% |
| CABOZANTINIB | - | 21 | 767 | 2,771 | 20.0% |
| BEVACIZUMAB | JOBEVNE | 19 | 17,498 | 23,114 | 22.4% |
| GEMCITABINE | Gemcitabine | 19 | 5,142 | 12,268 | 16.4% |